HONG KONG — Brunswick has hired Qing Xi as a partner in Shanghai while elevating Pru Bennett to the same role in Sydney.

Qing joins with a focus on healthcare and life sciences, having spent more than a decade with Pfizer. Most recently, Qing was VP of government affairs, market access and communications, overseeing the full scope of corporate affairs activities for Pfizer's established brands business in China. 

Prior to Pfizer, Qing worked at Intel supporting communications across China.

Corporate governance specialist Bennett, meanwhile, arrived at Brunswick as a senior advisor one year ago, after almost a decade as MD and head of investment stewardship for Blackrock in Asia-Pacific.

"Our clients will benefit greatly from their wealth of knowledge and senior counsel, as they navigate the increasingly complex environment across Asia," said Lisa Foley, who became Asia managing partner at Brunswick more than two years ago.